In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss ...
Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of ...
Latisha Doty, 46, and Alison Bocking, 48, have each lost more than 100 lbs.—and gained a lifelong friend in the process ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Explore the world of weight loss drugs. Find out how GLP-1-based drugs can lead to significant weight loss, but also bone and ...
The health risks of too much sugar have been made clear, but the billion-dollar global market to supply it is thriving. Sales of sweet treats remain strong, and waistlines keep expanding. Could weight ...
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...
Health Care Health Care   The Big Story MAHA leaders heading for clash over GLP-1 drugs Two of President-elect Trump’s top ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications. More than an estimated million Floridians are now using weight-loss medications, and experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback